HSIC vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

HSIC

55.9
AI Score
VS
HSIC Wins

XRAY

46.5
AI Score

Investment Advisor Scores

HSIC

56score
Recommendation
HOLD

XRAY

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HSIC XRAY Winner
Revenue 1.78B 6.83B HSIC
Net Income 27.00M 201.00M HSIC
Gross Margin 51.7% 31.8% XRAY
Net Margin 1.5% 2.9% HSIC
Operating Income 47.00M 353.00M HSIC
ROE 2.0% 6.4% HSIC
ROA 0.5% 1.8% HSIC
Total Assets 5.20B 11.38B HSIC
Current Ratio 1.63 1.32 XRAY

Relative Price Performance (Last 90 Days)

HSIC 1M: -6.1% · 3M: -2.0% XRAY 1M: -23.2% · 3M: -29.6%

Current Technical Phase

HSIC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.4 · Price: $84.88

XRAY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.3%), weak momentum, RSI 28

RSI (14): 27.8 · Price: $8.67

Fundamentals Snapshot

Metric HSIC XRAY
Market Cap — —
Forward P/E 14.2 5.8
Trailing P/E 24.5 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.3% 0.5%
Operating Margin 0.1% 0.1%
EPS 3.46 -2.69
Dividend Yield — 0.04%

Frequently Asked Questions

Based on our detailed analysis, HSIC is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.